Truncated VP3 protein as anti-tumor agent.
The present invention discloses proteinaceous apoptin-like containing truncated VP3 genes that can induce apoptosis in tumor cells or transformed cells. The functional truncated fragments having the same kind of activity and specificity as apoptin, possibly in different amounts. The truncated fragme...
| Main Authors: | , , |
|---|---|
| Format: | Patent |
| Published: |
2010
|
| Summary: | The present invention discloses proteinaceous apoptin-like containing truncated VP3 genes that can induce apoptosis in tumor cells or transformed cells. The functional truncated fragments having the same kind of activity and specificity as apoptin, possibly in different amounts. The truncated fragments are provided with a tag or fusion protein, and preferably the proteins are non-denatured.
|
|---|